RA Flashcards

1
Q

What is rheumatoid arthritis (RA)?

A

A systemic disease characterized by bilateral inflammatory arthritis that usually affects the small joints of the hands, wrists, and feet

RA has a prevalence estimated at 1%–2%, predominantly affecting women until age 60.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

At what age does the prevalence of RA equalize between genders?

A

After age 60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What type of disease is rheumatoid arthritis?

A

Autoimmune disease with a strong genetic predisposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are common symptoms of RA?

A
  • Joint pain and stiffness
  • Fatigue
  • Warmth, redness, and swelling of the joints
  • Symptoms usually have a symmetrical distribution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What laboratory tests are often positive in RA?

A
  • Rheumatoid factor (RF)
  • Elevated sedimentation rate
  • C-reactive protein
  • Anti–cyclic citrullinated peptide antibodies
  • Normochromic normocytic anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some extra-articular manifestations of RA?

A
  • Pulmonary fibrosis
  • Vasculitis
  • Dry eyes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the treatment goal for RA?

A

To control the inflammatory process leading to relief of pain, maintenance of function, and improved quality of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What non-pharmacologic treatments are recommended for RA?

A
  • Rest during exacerbation
  • Occupational and physical therapy
  • Maintenance of a normal weight
  • Assistive devices if needed
  • Surgery for tendons or joints
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the preferred initial treatment for DMARD-naive patients with low disease activity?

A

Hydroxychloroquine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the first-line DMARD for patients with moderate to high disease activity?

A

Methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What should be monitored to measure treatment response in RA?

A
  • Reduction in the number of affected joints
  • Improvement in pain
  • Decreased amount of morning stiffness
  • Reduction in serologic markers such as RF
  • Improvement in quality-of-life scales
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

True or False: NSAIDs affect disease progression in RA.

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the risk associated with glucocorticosteroids in RA treatment?

A

Adverse effects such as osteoporosis, infection risk, and cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the recommendation regarding the use of glucocorticosteroids in RA?

A

Short-term use (less than 3 months) is preferred to long-term use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which biologic DMARDs are commonly used for severe RA?

A
  • Etanercept
  • Infliximab
  • Adalimumab
  • Certolizumab
  • Golimumab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the recommended approach for patients with a history of tuberculosis or hepatitis B before starting biologic DMARDs?

A

Screening for tuberculosis and viral hepatitis is required

note: Immunizations are best given before initiating DMARDs or biologics. A 2-week waiting period is recommended.
Avoid live vaccines while the patient is taking DMARDs or biologics.

Patients with hepatitis B or C, if treated with effective antivirals, are treated the same as patients without hepatitis; however, with untreated disease, DMARDs are preferred to TNF inhibitors.

17
Q

What dietary supplements are recommended for patients with RA to prevent osteoporosis?

A
  • Calcium
  • Vitamin D
  • Bisphosphonates if prednisone 5 mg or more daily is prescribed
18
Q

What comorbid conditions are patients with RA at higher risk for?

A
  • Cardiovascular disease
  • Malignancy
  • Osteoporosis
19
Q

Fill in the blank: The initial goal of RA treatment is _______.

A

[low disease activity]

20
Q

What is the first line therapy?

A

Nonbiologic DMARDs are first line.

21
Q

For DMARD-naive patients with moderate to high
disease activity we use _______ _______ _______

A

Methotrexate, leflunomide, HCQ and Sulfasalazine

22
Q

Why oral methotrexate is preferred over subcutaneous?

A

because of ease of administration and similar bioavailability at
starting doses

23
Q

For DMARD-naive patients with low disease activity we use _______ _______ _______

A

Hydroxychloroquine recommended first line because
of low adverse effect profile.

Sulfasalazine recommended over methotrexate and
leflunomide: Sulfasalazine preferred in pregnancy.

24
Q

Who are candidates for combination DMARD therapy?

A

Some patients with poor prognostic indicators such as
functional limitation, extra-articular disease, positive RF,
anti–cyclic citrullinated peptide antibodies, or bony
erosions on radiography.

25
Q

What are biologic DMARDS?

A

i. Tumor necrosis factor (TNF) inhibitors: Etanercept,
infliximab,adalimumab,certolizumab,golimumab
ii. Non-TNF biologics: Abatacept, anakinra, rituximab,
tocilizumab, sarilumab
iii. Biologic kinase inhibitor: Tofacitinib, baricitinib,
Upadacitinib.

26
Q

Role of NSAIDS

A

NSAIDs do not affect disease progression in RA, their anti
inflammatory effect occurs within1–2 weeks of daily dosing, whereas the analgesic effect begins within several hours of administration.

27
Q

True or False: patient with congestive heart failure, it is recommended to avoid TNF inhibitors.

A

True

note: Cardiovascular disease(myocarditis and heart failure)causes 40% of all deaths inpatientswithRA.Low-doseaspirin, omega-3fatty
acids, statins, or combination therapy should be considered.

28
Q

special indications:

A

Use DMARDs over biologics in melanoma
use rituximab over TNF inhibitors in lymphoproliferative disorders.

Osteoporosis is more common in patients with RA.
Calcium and vitamin D are recommended. In addition,
bisphosphonates should be considered for prevention
if prednisone 5mg or more daily is prescribed.